Efg Asset Management (Americas) Corp. Roivant Sciences Ltd. Transaction History
Efg Asset Management (Americas) Corp.
- $508 Million
- Q3 2024
A detailed history of Efg Asset Management (Americas) Corp. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Efg Asset Management (Americas) Corp. holds 159,937 shares of ROIV stock, worth $1.78 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
159,937
Previous 138,690
15.32%
Holding current value
$1.78 Million
Previous $1.47 Million
25.94%
% of portfolio
0.36%
Previous 0.29%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
315Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$735 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$734 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$603 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$465 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$394 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.85B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...